# T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma

> **NCT01946373** · PHASE1 · UNKNOWN · sponsor: **Karolinska University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Melanoma

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Fludarabine
- **BIOLOGICAL:** T cells
- **BIOLOGICAL:** Interleukin-2
- **BIOLOGICAL:** Dendritic cell vaccine

## Key facts

- **NCT ID:** NCT01946373
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01946373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01946373, "T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01946373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*